White House Issues Report on Reforming Drug Pricing

A report from the White House Council of Economic Advisors released on February 9 asserts the need for major policy changes at the federal level in order to lower drug prices, including reforms impacting the FDA and changes to Medicare and Medicaid.

Read "Reforming Biopharmaceutical Pricing at Home and Abroad."

Posted 2/12/2018